Silencing long non-coding RNA SNHG6 restrains proliferation, migration and invasion of Wilms’ tumour cell lines by regulating miR-15a

References

• Breslow NE, Beckwith JB, Perlman EJ, et al. Age distributions, birth weights, nephrogenic rests, and heterogeneity in the pathogenesis of Wilms tumor. Pediatr Blood Cancer. 2006;47:260–267.
   PubMed Web of Science ®Google Scholar
• Wang H, Shen Y, Sun N, et al. Identification and analysis of mutations in WTX and WT1 genes in peripheral blood and tumor tissue of children with Wilms’ tumor. Chin Med J. 2012;125:1733–1739.
   PubMed Web of Science ®Google Scholar
• Maschietto M, Piccoli FS, Costa CM, et al. Gene expression analysis of blastemal component reveals genes associated with relapse mechanism in Wilms tumour. Eur J Cancer (Oxford, England: 1990). 2011;47:2715–2722.
   PubMed Web of Science ®Google Scholar
• Schaukowitch K, Kim TK. Emerging epigenetic mechanisms of long non-coding RNAs. Neuroscience. 2014;264:25–38.
   PubMed Web of Science ®Google Scholar
• Sun M, Kraus WL. From discovery to function: the expanding roles of long noncoding RNAs in physiology and disease. Endocr Rev. 2015;36:25–64.
   PubMed Web of Science ®Google Scholar
• Zhu S, Fu W, Zhang L, et al. LINC00473 antagonizes the tumour suppressor miR-195 to mediate the pathogenesis of Wilms tumour via IKKalpha. Cell Prolif. 2018;51:e12416.
   Web of Science ®Google Scholar
• Yan K, Tian J, Shi W, et al. LncRNA SNHG6 is associated with poor prognosis of gastric cancer and promotes cell proliferation and EMT through epigenetically silencing p27 and sponging miR-101-3p. Cell Physiol Biochem. 2017;42:999–1012.
   PubMed Web of Science ®Google Scholar
• Xu M, Chen X, Lin K, et al. lncRNA SNHG6 regulates EZH2 expression by sponging miR-26a/b and miR-214 in colorectal cancer. J Hematol Oncol. 2019;12:3.
   PubMed Web of Science ®Google Scholar
• Miska EA. How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev. 2005;15:563–568.
   PubMed Web of Science ®Google Scholar
• Tay Y, Kats L, Salmena L, et al. Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs. Cell. 2011;147:344–357.
   PubMed Web of Science ®Google Scholar
• Leucci E, Patella F, Waage J, et al. microRNA-9 targets the long non-coding RNA MALAT1 for degradation in the nucleus. Sci Rep. 2013;3:2535.
   PubMed Web of Science ®Google Scholar
• Li L, Hou X, Xu R, et al. Research review on the pharmacological effects of astragaloside IV. Fundam Clin Pharmacol. 2017;31:17–36.
   PubMed Web of Science ®Google Scholar
• Wang L, Zhang X, Sheng L, et al. LINC00473 promotes the Taxol resistance via miR-15a in colorectal cancer. Biosci Rep. 2018;38:BSR20180790.
   Web of Science ®Google Scholar
• Wu Y, Deng Y, Guo Q, et al. Long non-coding RNA SNHG6 promotes cell proliferation and migration through sponging miR-4465 in ovarian clear cell carcinoma. J Cell Mol Med. 2019. doi:10.1111/jcmm.14359
   Google Scholar
• Zhang M, Duan W, Sun W. LncRNA SNHG6 promotes the migration, invasion, and epithelial-mesenchymal transition of colorectal cancer cells by miR-26a/EZH2 axis. Onco Targets Ther. 2019;12:3349–3360.
   PubMed Web of Science ®Google Scholar
• Bhan A, Soleimani M, Mandal SS. Long noncoding RNA and cancer: a new paradigm. Cancer Res. 2017;77:3965–3981.
   PubMed Web of Science ®Google Scholar
• Lv P, Qiu X, Gu Y, et al. Long non-coding RNA SNHG6 enhances cell proliferation, migration and invasion by regulating miR-26a-5p/MAPK6 in breast cancer. Biomed Pharmacother = Biomed Pharmacother. 2019;110:294–301.
   PubMed Web of Science ®Google Scholar
• Li Z, Qiu R, Qiu X, et al. SNHG6 promotes tumor growth via repression of P21 in colorectal cancer. Cell Physiol Biochem. 2018;49:463–478.
   PubMedGoogle Scholar
• Li S, Huang Y, Huang Y, et al. The long non-coding RNA TP73-AS1 modulates HCC cell proliferation through miR-200a-dependent HMGB1/RAGE regulation. J Exp Clin Cancer Res: CR. 2017;36:51.
   PubMed Web of Science ®Google Scholar
• Li CF, Li YC, Wang Y, et al. The effect of LncRNA H19/miR-194-5p axis on the epithelial-mesenchymal transition of colorectal adenocarcinoma. Cell Physiol Biochem. 2018;50:196–213.
   PubMedGoogle Scholar
• Liu XH, Sun M, Nie FQ, et al. Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer. Mol Cancer. 2014;13:92.
   PubMed Web of Science ®Google Scholar
• Poliseno L, Haimovic A, Christos PJ, et al. Deletion of PTENP1 pseudogene in human melanoma. J Investig Dermatol. 2011;131:2497–2500.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Xing Y, Chi F, et al. Long noncoding RNA SNHG6 promotes the progression of colorectal cancer through sponging miR-760 and activation of FOXC1. Onco Targets Ther. 2018;11:5743–5752.
   PubMed Web of Science ®Google Scholar
• Renjie W, Haiqian L. MiR-132, miR-15a and miR-16 synergistically inhibit pituitary tumor cell proliferation, invasion and migration by targeting Sox5. Cancer Lett. 2015;356:568–578.
   PubMed Web of Science ®Google Scholar
• Gopalan V, Ebrahimi F, Islam F, et al. Tumour suppressor properties of miR-15a and its regulatory effects on BCL2 and SOX2 proteins in colorectal carcinomas. Exp Cell Res. 2018;370:245–253.
   PubMed Web of Science ®Google Scholar
• Feng H, Wei B, Zhang Y. Long non-coding RNA HULC promotes proliferation, migration and invasion of pancreatic cancer cells by down-regulating microRNA-15a. Int J Biol Macromol. 2019;126:891–898.
   PubMed Web of Science ®Google Scholar
• Ding Y, Yang H, Xiang W, et al. CD200R1 agonist attenuates LPS-induced inflammatory response in human renal proximal tubular epithelial cells by regulating TLR4-MyD88-TAK1-mediated NF-kappaB and MAPK pathway. Biochem Biophys Res Commun. 2015;460:287–294.
   PubMed Web of Science ®Google Scholar
• Sakurai H. Targeting of TAK1 in inflammatory disorders and cancer. Trends Pharmacol Sci. 2012;33:522–530.
   PubMed Web of Science ®Google Scholar
• Wu Q, Wu W, Fu B, et al. JNK signaling in cancer cell survival. Medicinal research reviews. 2019. doi:10.1002/med.21574
   Google Scholar
• Hirata Y, Sugie A, Matsuda A, et al. TAK1-JNK axis mediates survival signal through Mcl1 stabilization in activated T cells. J Immunol (Baltimore, Md: 1950). 2013;190:4621–4626.
   PubMed Web of Science ®Google Scholar
• Schneider JA, Logan SK. Revisiting the role of Wnt/beta-catenin signaling in prostate cancer. Mol Cell Endocrinol. 2018;462:3–8.
   PubMed Web of Science ®Google Scholar
• Chang HW, Roh JL, Jeong EJ, et al. Wnt signaling controls radiosensitivity via cyclooxygenase-2-mediated Ku expression in head and neck cancer. Int J Cancer. 2008;122:100–107.
   PubMed Web of Science ®Google Scholar
• Han P, Li JW, Zhang BM, et al. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/beta-catenin signaling. Mol Cancer. 2017;16:9.
   PubMed Web of Science ®Google Scholar